Outset Medical to Report First Quarter 2021 Financial Results on Wednesday, May 5, 2021

Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM) will announce its Q1 2021 financial results on May 5, 2021, after market close. A conference call with CEO Leslie Trigg and CFO Rebecca Chambers is scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss these results. Outset is known for its innovative Tablo Hemodialysis System, designed to simplify dialysis treatment and reduce costs, allowing for flexibility in care delivery from hospitals to home settings.

Positive

• Outset's Tablo Hemodialysis System improves dialysis cost and complexity.
• FDA clearance enables use of Tablo from hospital to home, expanding market reach.

Negative

• None.

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2021 after the close of trading on Wednesday, May 5, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Rebecca Chambers, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Wednesday, May 5, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 6787514. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210421005941/en/

FAQ

When will Outset Medical release its Q1 2021 financial results?

Outset Medical will release its Q1 2021 financial results on May 5, 2021, after market close.

What time is the conference call for Outset Medical's financial results?

The conference call will begin at 2:00 PM Pacific Time (5:00 PM Eastern Time) on May 5, 2021.

How can I access the conference call for Outset Medical?

The conference call can be accessed by calling (833) 614-1409 for domestic calls or (914) 987-7130 for international callers, using conference ID: 6787514.

What is the significance of the Tablo Hemodialysis System?

The Tablo Hemodialysis System represents a significant advancement in dialysis technology, allowing treatment to be delivered more easily and flexibly across various care settings.